logo

For the Inventor, By the Inventor

Danvers, MA, United States of America

Cell Signaling Technology, Inc.


USPTO Granted Patents = 61

% Expired Patents = 9.8



Trademarks = 25

Forward Citations = 247

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal Ailan Guo (29 out of 31 patents)

silverMedal Ting-Lei Gu (21 out of 21 patents)

bronzeMedal Herbert Haack (18 out of 18 patents)

4.  Anthony Paul Possemato (17 out of 17 patents)

5.  Klarisa Rikova (16 out of 28 patents)

6.  Michael Comb (13 out of 14 patents)

7.  Laura Sullivan (13 out of 13 patents)

8.  Jian Yu (13 out of 19 patents)

9.  Roberto Polakiewicz (13 out of 15 patents)

10.  Joan MacNeill (12 out of 12 patents)

11.  Albrecht Moritz (11 out of 12 patents)

12.  John Edward Rush, Ii (10 out of 11 patents)

13.  Katherine Eleanor Crosby (8 out of 8 patents)

14.  Yi Tan (8 out of 9 patents)

15.  Kimberly A Lee (7 out of 9 patents)


Core Competencies:
Mutant ALK Kinase
Cancer Diagnostics
ROS Expression
Polypeptide Detection
Mass Spectrometry
Monoclonal Antibodies
Signaling Pathways
Phosphorylation Sites
Immunoaffinity Isolation
EGFR Detection
Lung Cancer
Non-Small Cell Carcinoma

61 patents:

1. 12577295 - MOTIF-SPECIFIC AND CONTEXT-INDEPENDENT ANTIBODIES THAT SPECIFICALLY BIND TO A SUMOYLATED LYSINE-CONTAINING RESIDUE (2026-03-17),
2. 11761005 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2023-09-19),
3. 11505833 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2022-11-22),
4. 11428696 - Mass spectrometry analysis of mutant polypeptides in biological samples (2022-08-30),
5. 11377486 - Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue (2022-07-05),
6. 11352418 - Analysis of ubiquitinated polypeptides (2022-06-07),
7. 11099188 - ROS kinase in lung cancer (2021-08-24),
8. 10955416 - Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer (2021-03-23),
9. 10889818 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2021-01-12),
10. 10870892 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2020-12-22),
11. 10670606 - Mass spectrometry analysis of mutant polypeptides in biological samples (2020-06-02),
12. 10577640 - Multi component detection (2020-03-03),
13. 10551383 - Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer (2020-02-04),
14. 10526661 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2020-01-07),
15. 10036756 - Mass spectrometry analysis of mutant polypeptides in biological samples (2018-07-31),
Cell Signaling Technology, Inc. (CST) specializes in the development and production of high-quality antibodies, kits, and related reagents for life science research. With over 1,000 employees worldwide, CST is committed to advancing scientific research and discovery through innovation and excellence in biological reagents. Visit their website to explore their extensive product catalog and learn more about their groundbreaking solutions in cell signaling.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Cell Signaling Technology, Inc.
61 Patents

#3 in Danvers, MA

#335 in Massachusetts

#5,908 in US

#11,905 in the World

Danvers, MA (US)
Danvers, MA, United States of America

Cell Signaling Technology, Inc.

Forward Citations = 247

52 inventors:

goldMedal Ailan Guo (29 out of 31 patents)

silverMedal Ting-Lei Gu (21 out of 21 patents)

bronzeMedal Herbert Haack (18 out of 18 patents)

4.  Anthony Paul Possemato (17 out of 17 patents)

5.  Klarisa Rikova (16 out of 28 patents)

Please report any incorrect information to [email protected]
Loading…